Here's the live share price of RPG Life Sciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of RPG Life Sciences has gained 48.07% CAGR. Over the past year, the corresponding return has been -3.98%.
RPG Life Sciences’s current P/E of 18.97x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Consistently growing stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| RPG Life Sciences | 3.91 | 9.61 | 4.88 | 18.51 | -3.98 | 41.63 | 48.07 |
| Sun Pharmaceutical Industries | 0.33 | 2.35 | 3.15 | -7.76 | -6.42 | 17.65 | 27.40 |
| Divi's Laboratories | 6.12 | 17.18 | 5.13 | 11.31 | 15.80 | 22.16 | 16.40 |
| Cipla | -4.08 | -0.53 | -0.64 | -2.42 | -4.97 | 9.52 | 14.02 |
| Torrent Pharmaceuticals | -0.10 | 1.39 | -1.07 | 8.86 | 11.75 | 28.91 | 22.42 |
| Dr. Reddy's Laboratories | -6.95 | -3.82 | -2.01 | 2.41 | -5.30 | 9.89 | 4.00 |
| Zydus Lifesciences | -2.85 | -2.16 | 1.37 | 9.05 | -3.13 | 30.30 | 17.26 |
| Mankind Pharma | -1.47 | -3.37 | -9.86 | -1.93 | -13.37 | 18.50 | 10.72 |
| Lupin | 4.01 | 3.10 | 6.12 | -4.27 | -8.71 | 41.14 | 16.17 |
| Alkem Laboratories | 4.30 | 3.20 | 15.47 | 11.61 | -2.26 | 20.29 | 16.02 |
| Aurobindo Pharma | 4.77 | 5.10 | 5.60 | -7.30 | -18.14 | 27.67 | 8.06 |
| Abbott India | -1.34 | -2.12 | -13.63 | -4.47 | -0.20 | 14.70 | 13.16 |
| Laurus Labs | 2.36 | 13.77 | 14.00 | 58.86 | 101.49 | 28.34 | 28.79 |
| Glenmark Pharmaceuticals | 1.69 | -6.33 | -10.97 | 31.35 | 8.61 | 63.66 | 29.98 |
| Biocon | 3.92 | 9.50 | -0.58 | 13.22 | 22.27 | 11.53 | -1.52 |
| GlaxoSmithKline Pharmaceuticals | 0.21 | -2.66 | -7.06 | -7.98 | 1.93 | 25.53 | 13.79 |
| Anthem Biosciences | -1.49 | -8.06 | -6.71 | -3.81 | -3.81 | -1.29 | -0.77 |
| Ipca Laboratories | 0.77 | -2.12 | -10.29 | -6.88 | -18.52 | 12.62 | 1.79 |
| Ajanta Pharma | 8.79 | 6.76 | -1.59 | 0.20 | -13.37 | 27.38 | 19.28 |
| Gland Pharma | 0.17 | -1.74 | -3.80 | 34.33 | 18.38 | 1.73 | 0.92 |
Over the last one year, RPG Life Sciences has declined 3.98% compared to peers like Sun Pharmaceutical Industries (-6.42%), Divi's Laboratories (15.80%), Cipla (-4.97%). From a 5 year perspective, RPG Life Sciences has outperformed peers relative to Sun Pharmaceutical Industries (27.40%) and Divi's Laboratories (16.40%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,407.92 | 2,416.28 |
| 10 | 2,383.26 | 2,393.79 |
| 20 | 2,332.8 | 2,367.78 |
| 50 | 2,346.94 | 2,353.36 |
| 100 | 2,379.17 | 2,339.77 |
| 200 | 2,289.83 | 2,282.73 |
In the latest quarter, RPG Life Sciences remained same as its previous close in promoter holding, while DII stake increased to 6.70%, FII holding fell to 1.11%, and public shareholding moved up to 19.23% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,76,287 | 0.43 | 39.39 | |
| 55,596 | 0.73 | 12.42 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 25, 2025, 12:55 AM IST | RPG Life Sciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Oct 18, 2025, 8:13 PM IST | RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 18, 2025, 8:12 PM IST | RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 18, 2025, 2:02 AM IST | RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Oct 17, 2025, 11:58 PM IST | RPG Life Sciences - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) |
RPG Life Sciences Ltd. is a Public Limited Listed company incorporated on 29/03/2007 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24232MH2007PLC169354 and registration number is 169354. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 653.43 Cr. and Equity Capital is Rs. 13.23 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for RPG Life Sciences is ₹2,470.70 as on Nov 04, 2025.
The RPG Life Sciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of RPG Life Sciences is ₹4,086.29 Cr as on Nov 04, 2025.
Today’s highest and lowest price of RPG Life Sciences are ₹2,470.70 and ₹2,438.60.
The 52-week high/low is the highest and lowest price at which RPG Life Sciences stock has traded in the past 52-week or nearly a year. The 52-week high of RPG Life Sciences is ₹2,775.65 and 52-week low of RPG Life Sciences is ₹1,772.05 as on Nov 04, 2025.
The RPG Life Sciences has shown returns of 1.44% over the past day, 9.61% for the past month, 4.88% over 3 months, -3.98% over 1 year, 41.63% across 3 years, and 48.07% over 5 years.
P/E ratio of and PB ratio of RPG Life Sciences are 18.97 and 10.77 on Nov 04, 2025. While the company gives a dividend yield of 0.97 per annum.